37 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors.

Chia Tai Tianqing Pharmaceutical Group
Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity.

Chia Tai Tianqing Pharmaceutical Group
FUSED BICYCLIC COMPOUND CONTAINING PYRROLINONE

Chia Tai Tianqing Pharmaceutical Group
POLYAMIDE COMPOUNDS, METHOD FOR PREPARING SAME, AND MEDICAL USE THEREOF

Jiangsu Nhwa Pharmaceutical Co.
NOVEL BENZOTHIOPHENE DERIVATIVE AND USE THEREOF AS BET INHIBITOR

Benobio Co.
Aminonorbornane derivative and manufacture method therefor and use thereof

Transthera Sciences (Nanjing)
Cyclobutyl dihydroquinoline sulfonamide compounds

Amgen
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof

Nurix Therapeutics
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof

Genentech
SMALL-MOLECULAR INHIBITORS FOR THE BETA-CATENIN/ B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION

H. Lee Moffitt Cancer Center and Research Institute
Pyrazolo compounds and methods of use thereof

Genentech
6-AMINOPYRAZOLOPYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF

Japan Tobacco
NAMPT MODULATORS

Cytokinetics, Incorporated
FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS

University of Illinois
SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE

Individual
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto

Arena Pharmaceuticals
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS

Theravance Biopharma R&D Ip
HETEROARYLQUINAZOLINE COMPOUNDS AS PROTEIN KINASE INHIBITORS

Chengdu Cynogen Bio-Pharmaceutical Technology
Methods of inhibiting cyclooxygenase

King Faisal University
1H-IMIDAZO [4,5-H] QUINAZOLINE COMPOUND AS NOVEL SELECTIVE FLT3 INHIBITORS

Shengke Pharmaceuticals (Jiangsu)
3-(1H-IMIDAZOL-2-YL)-2,3,8,8A-TETRAHYDROINDOLIZIN-5(1H)-ONE DERIVATIVES USEFUL AS FACTOR XIA INHIBITORS

Janssen Pharmaceutica
Azaindole derivatives and their use as ERK kinase inhibitors

Agv Discovery
KRas G12D inhibitors

Mirati Therapeutics
Heterocyclic prolinamide derivatives

Orion Ophthalmology
Heterocyclic compounds for the inhibition of PASK

Bioenergenix
Carbazole derivatives

Bristol-Myers Squibb
KV1.3 inhibitors and their medical application

4Sc
Compositions useful for treating disorders related to kit

Blueprint Medicines
Oxoisoquinoline derivatives

Carna Biosciences
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

Eastern Virginia Medical School
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies

Galderma Research & Development
Inhibitors of RET

Blueprint Medicines
Synthesis and biological evaluation of novel series of aminopyrimidine derivatives as urease inhibitors and antimicrobial agents.

Solapur University
Triazolopyridinone PDE10 inhibitors

Merck Sharp & Dohme
Morpholinylbenzotriazines for use in cancer therapy

Merck Patent
Re(I) and Tc(I) complexes for targeting nitric oxide synthase: influence of the chelator in the affinity for the enzyme.

Universidade De Lisboa
Rosuvastatin and atorvastatin derivatives

Redx Pharma